Clarity Pharmaceuticals Revenue

In the fiscal year ending June 30, 2024, Clarity Pharmaceuticals had annual revenue of 11.51M AUD with 17.41% growth. Clarity Pharmaceuticals had revenue of 6.09M in the half year ending June 30, 2024, with 66.73% growth.

Revenue

11.51M

Revenue Growth

+17.41%

P/S Ratio

83.09

Revenue / Employee

230.13K

Employees

Market Cap

1.12B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	11.51M	1.71M	17.41%
Jun 30, 2023	9.80M	3.34M	51.74%
Jun 30, 2022	6.46M	3.26M	102.06%
Jun 30, 2021	3.20M	407.65K	14.62%
Jun 30, 2020	2.79M	145.32K	5.50%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	24.61B
Pro Medicus	184.58M
Cochlear	2.31B
Sonic Healthcare	9.33B
Telix Pharmaceuticals	783.21M
Ramsay Health Care	16.66B
Ansell	3.00B
Mesoblast	8.85M

Revenue Rankings

Clarity Pharmaceuticals News

2 months ago - Indoco Remedies stock surges 8% on partnership with Clarity Pharma in the UK - Business Upturn
2 months ago - Indoco Remedies partners with Clarity Pharma to strengthen UK presence - Business Upturn
4 months ago - Rising Shares at Clarity Pharmaceuticals as it Launches Second Phase III Trial and Promotes Michelle Parker to CEO - CEOWORLD magazine
7 months ago - Three ASX companies jockeying to be the next biotech winners - The Australian Financial Review

More News